ARS Pharmaceuticals (SPRY) Short Interest Ratio & Short Volume → Could Bitcoin Literally FORCE This Crypto To Rocket Up? (From Paradigm Press) (Ad) Free SPRY Stock Alerts $9.06 -0.12 (-1.31%) (As of 04:28 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media ARS Pharmaceuticals Short Interest DataCurrent Short Volume5,500,000 sharesPrevious Short Volume4,250,000 sharesChange Vs. Previous Month+29.41%Dollar Volume Sold Short$56.21 millionShort Interest Ratio / Days to Cover8.5Last Record DateMarch 31, 2024Outstanding Shares96,500,000 sharesFloat Size41,880,000 sharesShort Percent of Float13.13%Today's Trading Volume415,806 sharesAverage Trading Volume617,112 sharesToday's Volume Vs. Average67% Short Selling ARS Pharmaceuticals ? Sign up to receive the latest short interest report for ARS Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatSPRY Short Interest Over TimeSPRY Days to Cover Over TimeSPRY Percentage of Float Shorted Over Time Ad Paradigm PressCould Bitcoin Literally FORCE This Crypto To Rocket Up?Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…>>Click here to find out what it is. ARS Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/20245,500,000 shares $56.21 million +29.4%13.1%8.5 $10.22 3/15/20244,250,000 shares $38.93 million -7.8%10.2%7.3 $9.16 2/29/20244,610,000 shares $38.59 million -5.1%11.2%10 $8.37 2/15/20244,860,000 shares $35.28 million No Change11.8%11.3 $7.26 1/31/20244,860,000 shares $30.18 million -30.0%11.8%11.4 $6.21 1/15/20246,940,000 shares $41.02 million -0.4%16.9%13.8 $5.91 Get the Latest News and Ratings for SPRY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ARS Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 12/31/20236,970,000 shares $38.20 million +4.3%16.9%12.6 $5.48 12/15/20236,680,000 shares $34.80 million +10.8%16.2%9.3 $5.21 11/30/20236,030,000 shares $29.12 million +1.5%14.7%4.4 $4.83 11/15/20235,940,000 shares $26.91 million -10.0%14.6%4.3 $4.53 10/31/20236,600,000 shares $23.56 million +16.4%16.2%5 $3.57 10/15/20235,670,000 shares $21.15 million -3.4%14.0%4.6 $3.73 9/30/20235,870,000 shares $22.19 million +1.6%14.5%4.9 $3.78 9/15/20235,780,000 shares $41.96 million +7.6%14.2%5.1 $7.26 8/31/20235,370,000 shares $38.07 million -7.7%10.4%10.2 $7.09 8/15/20235,820,000 shares $40.97 million -4.1%12.2%9.7 $7.04 7/31/20236,070,000 shares $44.61 million -2.7%12.8%3.7 $7.35 7/15/20236,240,000 shares $42.62 million +5.2%13.1%3.8 $6.83 6/30/20235,930,000 shares $39.73 million +9.4%12.5%3.7 $6.70 6/15/20235,420,000 shares $32.79 million +22.4%11.4%3.4 $6.05 5/31/20234,430,000 shares $30.83 million +22.4%9.4%3 $6.96 5/15/20233,620,000 shares $28.27 million No Change7.7%2.7 $7.81 SPRY Short Interest - Frequently Asked Questions What is ARS Pharmaceuticals' current short interest? Short interest is the volume of ARS Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of March 31st, investors have sold 5,500,000 shares of SPRY short. 13.13% of ARS Pharmaceuticals' shares are currently sold short. Learn More on ARS Pharmaceuticals' current short interest. What is a good short interest ratio for ARS Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SPRY shares currently have a short interest ratio of 8.0. Learn More on ARS Pharmaceuticals's short interest ratio. Which institutional investors are shorting ARS Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of ARS Pharmaceuticals: Citadel Advisors LLC, Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for ARS Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 13.13% of ARS Pharmaceuticals' floating shares are currently sold short. Is ARS Pharmaceuticals' short interest increasing or decreasing? ARS Pharmaceuticals saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 5,500,000 shares, an increase of 29.4% from the previous total of 4,250,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is ARS Pharmaceuticals' float size? ARS Pharmaceuticals currently has issued a total of 96,500,000 shares. Some of ARS Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. ARS Pharmaceuticals currently has a public float of 41,880,000 shares. How does ARS Pharmaceuticals' short interest compare to its competitors? 13.13% of ARS Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to ARS Pharmaceuticals: Pliant Therapeutics, Inc. (12.38%), Tyra Biosciences, Inc. (14.91%), Innoviva, Inc. (18.15%), ABIVAX Société Anonyme (0.27%), Nurix Therapeutics, Inc. (14.18%), OPKO Health, Inc. (28.56%), Tango Therapeutics, Inc. (19.42%), Sage Therapeutics, Inc. (17.53%), Enliven Therapeutics, Inc. (19.82%), 89bio, Inc. (12.35%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short ARS Pharmaceuticals stock? Short selling SPRY is an investing strategy that aims to generate trading profit from ARS Pharmaceuticals as its price is falling. SPRY shares are trading down $0.12 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against ARS Pharmaceuticals? A short squeeze for ARS Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SPRY, which in turn drives the price of the stock up even further. How often is ARS Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SPRY, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: Pliant Therapeutics Short Interest Data Tyra Biosciences Short Interest Data Innoviva Short Interest Data ABIVAX Société Anonyme Short Interest Data Nurix Therapeutics Short Interest Data OPKO Health Short Interest Data Tango Therapeutics Short Interest Data Sage Therapeutics Short Interest Data Enliven Therapeutics Short Interest Data 89bio Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SPRY) was last updated on 4/17/2024 by MarketBeat.com Staff From Our Partners#1 Crypto of 2024True Market InsidersHe Is Giving Away BitcoinCrypto Swap Profits[Urgent!] Generational Wealth GameplanCrypto 101 MediaThe “Perfect Storm” for GoldGold Safe ExchangeThe "Smart Money" Is Ready for May 1st Are You?Stansberry ResearchTop 5 AI Stocks to Buy for 2024Market Moving TrendsOptions trading has suddenly become more reliable.Eagle PublishingTop 5 Tech Stocks to Buy for 2024Daily Market Alerts